Your browser doesn't support javascript.
loading
Outcomes of a Multicenter Training Program in Robotic Pancreatoduodenectomy (LAELAPS-3).
Zwart, Maurice J W; Nota, Carolijn L M; de Rooij, Thijs; van Hilst, Jony; Te Riele, Wouter W; van Santvoort, Hjalmar C; Hagendoorn, Jeroen; Borei Rinkes, Inne H M; van Dam, Jacob L; Latenstein, Anouk E J; Takagi, Kosei; Tran, Khé T C; Schreinemakers, Jennifer; van der Schelling, George P; Wijsman, Jan H; Festen, Sebastiaan; Daams, Freek; Luyer, Misha D; de Hingh, Ignace H J T; Mieog, Jan S D; Bonsing, Bert A; Lips, Daan J; Hilal, Mohammed Abu; Busch, Olivier R; Saint-Marc, Olivier; Zehl, Herbert J; Zureikat, Amer H; Hogg, Melissa E; Molenaar, I Quintus; Besselink, Marc G; Koerkamp, Bas Groot.
Afiliação
  • Zwart MJW; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Nota CLM; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • de Rooij T; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • van Hilst J; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Te Riele WW; Department of Surgery, OLVG, Amsterdam, the Netherlands.
  • van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
  • Hagendoorn J; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
  • Borei Rinkes IHM; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
  • van Dam JL; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
  • Latenstein AEJ; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
  • Takagi K; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Tran KTC; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Schreinemakers J; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van der Schelling GP; Department of Surgery, Amphia Ziekenhuis, Breda, the Netherlands.
  • Wijsman JH; Department of Surgery, Amphia Ziekenhuis, Breda, the Netherlands.
  • Festen S; Department of Surgery, Amphia Ziekenhuis, Breda, the Netherlands.
  • Daams F; Department of Surgery, OLVG, Amsterdam, the Netherlands.
  • Luyer MD; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
  • de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Mieog JSD; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Lips DJ; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Hilal MA; Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Busch OR; Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.
  • Saint-Marc O; Department of Surgery, Istituto Fondazione Poliambulanza, Brescia, Italy.
  • Zehl HJ; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Zureikat AH; Department of Surgery, Centre Hospitalier Regional Orleans, Orleans, France.
  • Hogg ME; Department of Surgery, University of Texas, Southwestern, Dallas, Texas.
  • Molenaar IQ; Department of Surgery, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Besselink MG; Department of Surgery, Northshore University HealthSystem, Chicago, Illinois.
  • Koerkamp BG; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.
Ann Surg ; 276(6): e886-e895, 2022 12 01.
Article em En | MEDLINE | ID: mdl-33534227
ABSTRACT

OBJECTIVE:

To assess feasibility and safety of a multicenter training program in robotic pancreatoduodenectomy (RPD) adhering to the IDEAL framework for implementation of surgical innovation.

BACKGROUND:

Good results for RPD have been reported from single center studies. However, data on feasibility and safety of implementation through a multicenter training program in RPD are lacking.

METHODS:

A multicenter training program in RPD was designed together with the University of Pittsburgh Medical Center, including an online video bank, robot simulation exercises, biotissue drills, and on-site proctoring. Benchmark patients were based on the criteria of Clavien. Outcomes were collected prospectively (March 2016-October 2019). Cumulative sum analysis of operative time was performed to distinguish the first and second phase of the learning curve. Outcomes were compared between both phases of the learning curve. Trends in nationwide use of robotic and laparoscopic PD were assessed in the Dutch Pancreatic Cancer Audit.

RESULTS:

Overall, 275 RPD procedures were performed in seven centers by 15 trained surgeons. The recent benchmark criteria for low-risk PD were met by 125 (45.5%) patients. The conversion rate was 6.5% (n = 18) and median blood loss 250ml [interquartile range (IQR) 150-500]. The rate of Clavien-Dindo grade ≥III complications was 44.4% (n = 122), postoperative pancreatic fistula (grade B/C) rate 23.6% (n = 65), 90-day complication-related mortality 2.5% (n = 7) and 90-day cancer-related mortality 2.2.% (n = 6). Median postoperative hospital stay was 12 days (IQR 8-20). In the subgroup of patients with pancreatic cancer (n = 80), the major complication rate was 31.3% and POPF rate was 10%. Cumulative sum analysis for operative time found a learning curve inflection point at 22 RPDs (IQR 10-35) with similar rates of Clavien-Dindo grade ≥III complications in the first and second phase (43.4% vs 43.8%, P = 0.956, respectively). During the study period the nationwide use of laparoscopic PD reduced from 15% to 1%, whereas the use of RPD increased from 0% to 25%.

CONCLUSIONS:

This multicenter RPD training program in centers with sufficient surgical volume was found to be feasible without a negative impact of the learning curve on clinical outcomes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Robótica / Laparoscopia / Procedimentos Cirúrgicos Robóticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Robótica / Laparoscopia / Procedimentos Cirúrgicos Robóticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article